Efficacy and Safety of Combined With Immunotherapy After Induction Therapy With Chemotherapy and Targeted Therapy in the First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer
Clinical trial NCT06176885 · RECRUITING
Trial details
- NCT number
- NCT06176885
- Sponsor
- yue junhan
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-20
- Primary completion
- 2025-12-20
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.